Booking Holdings
BKNG
$207.02
+6.56%
Booking Holdings is the world's largest online travel agency by sales, operating a portfolio of leading travel booking platforms including Booking.com, Agoda, Kayak, OpenTable, and Rentalcars.com, which facilitate reservations for accommodations, flights, rental cars, and experiences. As a dominant player in the global online travel market, the company leverages its scale, brand recognition, and technology to connect travelers with a vast inventory of travel services. The current investor narrative centers on the company's resilience amid geopolitical tensions, particularly the Middle East conflict that has disrupted travel demand and led to a guidance cut for 2026, despite a strong Q1 earnings beat. Additionally, the recent 10-for-1 stock split has attracted retail attention, while analysts debate the sustainability of growth in a challenging macro environment.…
BKNG
Booking Holdings
$207.02
Related headlines
Investment Opinion: Should I buy BKNG Today?
Based on the analysis, BKNG is rated a Buy. The thesis is that the company's strong Q1 performance, with revenue growth of 16.17% and net income up 225%, combined with a forward PE of 15.70x, offers an attractive risk/reward. The analyst consensus is Buy with an average target of $224.42, implying a 16.3% upside. Supporting evidence includes the accelerating revenue growth, expanding operating margins, and strong free cash flow of $9.033B. The stock is trading at a PS ratio of 6.46x, which is above the sector average, but the forward PE suggests undervaluation relative to future earnings. The main risks are geopolitical disruptions and potential multiple compression. If the Middle East conflict escalates, the stock could drop to the 52-week low of $150.14, a -22.2% downside. However, if travel demand recovers, the stock could reach the high target of $298, a 54.5% upside. Overall, the stock is fairly valued to slightly undervalued based on forward earnings, but the wide target range reflects uncertainty.
Sign up to view all
BKNG 12-Month Price Forecast
The AI assessment is neutral with medium confidence. The strong Q1 results and attractive forward valuation are offset by geopolitical risks and underperformance. The stock is trading at a discount to its forward earnings, but the uncertainty surrounding travel demand makes it a balanced risk/reward. If the Middle East conflict resolves and travel demand recovers, the stock could see significant upside. Conversely, if the conflict escalates, the stock could test new lows. The AI stance would upgrade to bullish if the company raises guidance or if geopolitical tensions ease, and downgrade to bearish if the conflict worsens or if revenue growth decelerates below 10%.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Booking Holdings's 12-month outlook, with a consensus price target around $224.72 and implied upside of +8.6% versus the current price.
Average Target
$224.72
0 analysts
Implied Upside
+8.6%
vs. current price
Analyst Count
—
covering this stock
Price Range
$175 - $298
Analyst target range
The target price range spans from a low of $175.00 to a high of $298.00, reflecting a wide dispersion of 70.3% between the low and high estimates. The high target of $298 implies a 54.5% upside, suggesting that some analysts see significant recovery potential, possibly driven by a normalization of travel demand and margin expansion. The low target of $175 is 9.3% below the current price, indicating downside risks from prolonged geopolitical disruptions or weaker consumer spending. The recent ratings actions have been mostly reaffirmations of existing stances, with no major upgrades or downgrades, suggesting stability in analyst sentiment. The wide target range highlights the uncertainty surrounding the recovery trajectory, but the overall consensus remains positive.
Bulls vs Bears: BKNG Investment Factors
Booking Holdings presents a mixed picture: strong Q1 results with accelerating revenue and robust profit growth are offset by geopolitical risks that have led to guidance cuts and stock underperformance. The bull case is supported by improving fundamentals and a compelling forward valuation, while the bear case centers on ongoing travel disruptions and a rich trailing multiple. Currently, the evidence slightly favors the bulls due to the significant earnings growth potential and analyst consensus, but the key tension is whether the Middle East conflict will continue to suppress travel demand, which would invalidate the recovery thesis.
Bullish
- Strong Q1 Revenue Acceleration: Q1 2026 revenue grew 16.17% YoY to $5.532B, up from 4.76% growth in Q1 2025, indicating accelerating demand. This was driven by strong merchant and agency revenue, showcasing the company's ability to capture travel demand.
- Significant Net Income Improvement: Net income surged to $1.083B in Q1 2026 from $333M in Q1 2025, a 225% increase. This reflects strong operating leverage and cost discipline, boosting EPS to $1.37 from $0.41.
- Expanding Operating Margins: Operating margin improved to 22.98% in Q1 2026 from 22.30% in Q1 2025, despite higher marketing spend. This demonstrates efficiency gains and pricing power, supporting profitability.
- Attractive Forward Valuation: Forward PE of 15.70x is well below trailing PE of 32.16x, implying the market expects substantial earnings growth. This suggests the stock is undervalued relative to future earnings potential.
Bearish
- Geopolitical Disruptions Impacting Guidance: The Middle East conflict, particularly the Hormuz crisis, led to a guidance cut for 2026, overshadowing Q1 earnings. This highlights vulnerability to geopolitical events that can disrupt travel demand.
- Stock Underperforming Market: BKNG declined 12.38% over the past year, while the S&P 500 gained 18.19%. This underperformance reflects persistent headwinds and investor skepticism about recovery.
- High Trailing PE Indicates Rich Valuation: The trailing PE of 32.16x is above the sector average, suggesting the market is pricing in perfection. If growth disappoints, the stock could face multiple compression.
- Negative Relative Strength: Relative strength over 1 year is -30.57%, indicating significant underperformance. This suggests ongoing selling pressure and weak momentum, which could persist.
BKNG Technical Analysis
The stock is in a recovery phase after a significant downtrend, with the current price of $192.90 sitting 16.8% above its 52-week low of $150.14 but still 16.8% below the 52-week high of $231.80. Over the past year, BKNG has declined 12.38%, underperforming the S&P 500's gain of 18.19%, reflecting a period of sustained weakness. The price is currently at 62.5% of its 52-week range, indicating a partial recovery from the lows but still below the highs, suggesting a cautious optimism as the stock attempts to rebuild momentum.
Beta
1.07
1.07x market volatility
Max Drawdown
-33.8%
Largest decline past year
52-Week Range
$150-$232
Price range past year
Annual Return
-5.2%
Cumulative gain past year
| Period | BKNG Return | S&P 500 |
|---|---|---|
| 1m | +14.4% | +2.5% |
| 3m | +20.9% | +5.2% |
| 6m | +16.1% | +11.5% |
| 1y | -5.2% | +22.6% |
| ytd | -2.8% | +12.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
BKNG Fundamental Analysis
Revenue for Q1 2026 was $5.532 billion, up 16.17% year-over-year, accelerating from the 4.76% growth seen in Q1 2025. This growth was driven by strong performance in merchant revenue ($3.698 billion) and agency revenue ($1.528 billion), with advertising and other revenues contributing $306 million. The company's net income for Q1 2026 was $1.083 billion, a significant improvement from $333 million in the year-ago quarter, reflecting robust operating leverage. Gross margin remains at 100% due to the agency model, while operating margin expanded to 22.98% from 22.30% in Q1 2025, indicating improved cost efficiency.
Quarterly Revenue
$5.5B
2026-03
Revenue YoY Growth
+16.2%
YoY Comparison
Gross Margin
100.0%
Latest Quarter
Free Cash Flow
$9.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is BKNG Overvalued?
Given the positive net income, the PE ratio is the primary valuation metric. The trailing PE is 32.16x, while the forward PE is 15.70x, implying the market expects substantial earnings growth. This gap suggests that analysts anticipate a significant rebound in earnings, likely driven by recovery in travel demand and cost controls. The PS ratio of 6.46x is above the sector average, reflecting a premium valuation for the market leader.
PE
32.2x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 10x~53x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
19.1x
Enterprise Value Multiple
Investment Risk Disclosure
Financial risks include a negative debt-to-equity ratio of -3.46, indicating that the company has more cash than debt, which is a positive sign. However, the company's net margin of 20.08% is solid, but the high payout ratio of 23.09% suggests a commitment to returning capital, which could limit reinvestment. The free cash flow of $9.033B TTM is strong, but the company's reliance on continued growth to justify its valuation is a risk if growth decelerates. Additionally, the company's operating margin of 34.48% is impressive, but any margin compression could impact earnings significantly.
FAQ
The key risks include: 1) Geopolitical disruptions, such as the Middle East conflict, which can severely impact travel demand and lead to guidance cuts. 2) Valuation risk, as the trailing PE of 32.16x is high, and any growth deceleration could lead to multiple compression. 3) Competitive risk from other OTAs and direct booking channels. 4) Macroeconomic risk, as a recession could reduce consumer spending on travel. The most severe risk is a prolonged geopolitical crisis, which could drive the stock down to the 52-week low of $150.14, a -22.2% downside.
The 12-month forecast for BKNG is based on three scenarios. The bull case (30% probability) targets $224-$298, driven by a resolution of the Middle East conflict and strong travel demand. The base case (50% probability) targets $200-$224, assuming gradual recovery and meeting expectations. The bear case (20% probability) targets $150-$175, if the conflict worsens and travel demand declines. The most likely scenario is the base case, with a target around $224, as analysts expect a gradual recovery. The key assumption is that geopolitical tensions do not escalate significantly.
BKNG is trading at a trailing PE of 32.16x, which is above the sector average, but the forward PE of 15.70x is much lower, indicating that the market expects significant earnings growth. The PS ratio of 6.46x is also above the sector average, suggesting a premium valuation. However, given the company's strong growth and market leadership, the stock is fairly valued to slightly undervalued based on forward earnings. The market is pricing in a recovery in travel demand, and if that materializes, the stock could be undervalued. If growth disappoints, the stock could be overvalued.
BKNG is a good buy for investors with a medium-to-long-term horizon who can tolerate geopolitical risks. The stock offers a 16.3% upside to the average analyst target of $224.42, and the forward PE of 15.70x suggests undervaluation relative to future earnings. However, the stock is down 12.38% over the past year, and the Middle East conflict poses a significant risk. If you believe travel demand will recover, the risk/reward is favorable. But if the conflict escalates, the stock could fall to the 52-week low of $150.14, a -22.2% downside. Overall, it's a buy for those with a higher risk tolerance.
BKNG is more suitable for long-term investment, given its growth potential and market leadership. The stock has a beta of 1.075, indicating moderate volatility, and has underperformed the market over the past year. However, the forward PE of 15.70x suggests that the market expects strong earnings growth, which could take time to materialize. For short-term traders, the stock may offer opportunities based on news and geopolitical developments, but the high uncertainty makes it risky. A minimum holding period of 12-18 months is recommended to allow for the recovery thesis to play out.